| Literature DB >> 29432565 |
Dai Wang1,2, Sean P McAteer1, Agata B Wawszczyk1,3, Clark D Russell1, Amin Tahoun1,4, Alex Elmi5, Scott L Cockroft5, David Tollervey6, Sander Granneman3, Jai J Tree1,6,7, David L Gally1.
Abstract
The prokaryotic RNA chaperone Hfq mediates sRNA-mRNA interactions and plays a significant role in post-transcriptional regulation of the type III secretion (T3S) system produced by a range of Escherichia coli pathotypes. UV-crosslinking was used to map Hfq-binding under conditions that promote T3S and multiple interactions were identified within polycistronic transcripts produced from the locus of enterocyte effacement (LEE) that encodes the T3S system. The majority of Hfq binding was within the LEE5 and LEE4 operons, the latter encoding the translocon apparatus (SepL-EspADB) that is positively regulated by the RNA binding protein, CsrA. Using the identified Hfq-binding sites and a series of sRNA deletions, the sRNA Spot42 was shown to directly repress translation of LEE4 at the sepL 5' UTR. In silico and in vivo analyses of the sepL mRNA secondary structure combined with expression studies of truncates indicated that the unbound sepL mRNA is translationally inactive. Based on expression studies with site-directed mutants, an OFF-ON-OFF toggle model is proposed that results in transient translation of SepL and EspA filament assembly. Under this model, the nascent mRNA is translationally off, before being activated by CsrA, and then repressed by Hfq and Spot42.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29432565 PMCID: PMC5909449 DOI: 10.1093/nar/gky096
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.The RNA chaperone, Hfq, binds multiple sites within the polycistronic mRNAs of the LEE. (A) The circular plot defines the location of Hfq-associated RNA sequences within the E. coli O157 Sakai genome; shown for both strands based on our previous Hfq UV-crosslinking study (Materials and Methods, (31)). The location of integrated and cryptic prophage elements (Sp), and the Locus of Enterocyte Effacement (LEE) are on the inner ring indicated (grey boxes). (B) Hfq binding across the LEE. Genomic features within the LEE are shown (centre, grey boxes), including the five polycistronic LEE operons (LEE1–5, green boxes) and grlRA. Positive strand features are shown above the genomic features and negative strand below. Hfq binding sites identified by UV-crosslinking (31) are shown in blue for triplicate datasets. From this data, non-genomically encoded oligo(A) tails (indicative of RNA cleavage sites) were also extracted and plotted in red. Replicate control (wild type untagged Hfq) are also shown in blue and represent the background recovery of mRNAs under our experimental conditions. Deletions in sequencing reads are indicative of direct Hfq-RNA contact and are plotted in green for each Hfq UV-crosslinking experiment. (C) Hfq binding sites with the 5′ UTR and 5′ end of sepL are shown from two rounds of Hfq-CRAC analysis. The mapping indicates two predominant sites of Hfq interaction at peaks 702 and 703 (indicated by arrowheads). (D) Hfq binding at the grlRA dicistronic mRNA. Replicate Hfq UV-crosslinking experiments are presented. (E) Hfq-binding to the 5′ UTR and first 100nt of the master regulator of the LEE, ler. Replicate Hfq UV-crosslinking experiments are shown. (F) Diagram of the LEE4 operon. The operons in the Locus of Enterocyte Effacement (LEE) are ordered LEE1, 2, 3, 5, 4 (opposite direction to that shown in panel B) and LEE4 is positioned after LEE5 and the escD promotor (shown). The operon extends from sepL, through the translocon-encoding genes, espADB, and three genes including escF that encodes a needle structure over which the EspA filament is assembled. The polycistronic mRNA is expressed from a promoter (P) in front of sepL. The LEE4 mRNA is processed by an RNaseE site in the 3′ end of sepL (29).
Bacterial strains, media, plasmids and primers used in this study
| Strains | Details/reference | Plasmids used for construction (if required) |
|---|---|---|
| ZAP193 |
| |
| Sakai | Dahan | |
| Sakai s | Tree | |
| ZAP1419 | ZAP193: | pDW-mFft then pDW-mFf2 |
| ZAP1420 | ZAP193: | pDW-mAft then pDW-mAf2 |
| ZAP1421 | ZAP193: | pDW-bBft then pDW-bBf2 |
| ZAP1422 | ZAP193: | pDW-hBft then pDW-hBf2 |
| ZAP1423 | ZAP193: | pDW-oAft then pDW-oAf2 |
| ZAP1424 | ZAP193: | pDW-oBft then pDW-oBf2 |
| ZAP1425 | ZAP193: | pDW-sfft then pDW-sff2 |
| ZAP1426 | ZAP193: | pDW-fSft then pDW-fSf2 |
| ZAP1427 | ZAP193: | pDW-mSft then pDW-mSf2 |
| ZAP1428 | ZAP193: | pDW-rAft then pDW-rAf2 |
| ZAP1429 | Sakai: | pDW-mFft then pDW-mFf2 |
| ZAP1430 | Sakai: | pDW-mAft then pDW-mAf2 |
| ZAP1431 | Sakai: | pDW-bBft then pDW-bBf2 |
| ZAP1432 | Sakai: | pDW-hBft then pDW-hBf2 |
| ZAP1433 | Sakai: | pDW-oAft then pDW-oAf2 |
| ZAP1434 | Sakai: | pDW-oBft then pDW-oBf2 |
| ZAP1435 | Sakai: | pDW-sfft then pDW-sff2 |
| ZAP1436 | Sakai: | pDW-fSft then pDW-fSf2 |
| ZAP1437 | Sakai: | pDW-mSft then pDW-mSf2 |
| ZAP1438 | Sakai: | pDW-rAft then pDW-rAf2 |
| ZAP1415 | Sakai: | pDW-sfft |
| ZAP1772 | Sakai: | pIB-spf |
| ZAP1773 | Sakai: | pIB-spf-S1 |
| ZAP1774 | Sakai: | pIB-spf-S2 |
Plasmids used in this study
| Plasmids | Details |
|---|---|
| pIB307 | pMAK705-based vector for allelic exchange; temperature-sensitive replicon ( |
| pDW-mAf2 | pIB307 containing upstream and downstream flanking regions of |
| pDW-mFf2 | pIB307 containing upstream and downstream flanking regions of |
| pDW-hBf2 | pIB307 containing upstream and downstream flanking regions of |
| pDW-bBf2 | pIB307 containing upstream and downstream flanking regions of rybB |
| pDW-sff2 | pIB307 containing upstream and downstream flanking regions of |
| pDW-oAf2 | pIB307 containing upstream and downstream flanking regions of |
| pDW-oBf2 | pIB307 containing upstream and downstream flanking regions of |
| pDW-rAf2 | pIB307 containing upstream and downstream flanking regions of |
| pDW-fSf2 | pIB307 containing upstream and downstream flanking regions of |
| pDW-mSf2 | pIB307 containing upstream and downstream flanking regions of |
| pDW-mAft | pDW-mAf2 + |
| pDW-mFft | pDW-mFf2 + |
| pDW-hBft | pDW-hBf2 + |
| pDW-bBft | pDW-bBf2 + |
| pDW-sfft | pDW-sff2 + |
| pDW-oAft | pDW-oAf2 + |
| pDW-oBft | pDW-oBf2 + |
| pDW-rAft | pDW-rAf2 + |
| pDW-fSft | pDW-fSf2 + |
| pDW-mSft | pDW-mSf2 + |
| pTOF61 | A plasmid derived from pTOF1 ( |
| pDG028 | Low-copy-number vector containing |
| pDW6 | pAJR70 digested with |
| pDW-LEE1 | Encodes full length Ler fusion to GFP expressed from WT promoter ( |
| pDW-LEE5 | Encodes full length Tir fusion to GFP expressed from WT promoter ( |
| pDW26 | First 51bp of sepL cloned in frame to egfp in pAJR70 ( |
| pDW6-S1 | Mutation of |
| pDW6-S2 | Mutation of |
| pDW6-S3 | Mutation of |
| pDW6-C1 | Mutation of |
| pDW6-C2 | Mutation of |
| pDW6-C3 | Mutation of |
| pDW6-C4 | Mutation of |
| pDW6-C5 | Mutation of |
| pDW6-H1 | Mutation of |
| pIB-spf | pIB307 containing spf plus upstream and downstream flanking regions |
| pIB-spf-S1 | pIB-spf mutated with S1 primers |
| pIB-spf-S2 | pIB-spf mutated with S2 primers |
Primers used in this study
| Primer | Sequence | Application |
|---|---|---|
| micA55 | CCC | pDW-mAf2 |
| micA53 | GC | pDW-mAf2 |
| micA35 | GC | pDW-mAf2 |
| micA33 | GG | pDW-mAf2 |
| micF55 | CCC | pDW-mFf2 |
| micF53 | GC | pDW-mFf2 |
| micF35 | GC | pDW-mFf2 |
| micF33 | CG | pDW-mFf2 |
| ryhB55 | CCC | pDW-hBf2 |
| ryhB53 | CG | pDW-hBf2 |
| ryhB35 | CG | pDW-hBf2 |
| ryhB33 | GG | pDW-hBf2 |
| mcaS55 | GC | pDW-mSf2 |
| mcaS53 | CG | pDW-mSf2 |
| mcaS35 | CG | pDW-mSf2 |
| mcaS33 | GG | pDW-mSf2 |
| rybB55 | CCC | pDW-bBf2 |
| rybB53 | GC | pDW-bBf2 |
| rybB35 | GC | pDW-bBf2 |
| rybB33 | CG | pDW-bBf2 |
| rprA55 | GC | pDW-rAf2 |
| rprA53 | CG | pDW-rAf2 |
| rprA35 | CG | pDW-rAf2 |
| rprA33 | GG | pDW-rAf2 |
| fnrS55 | C | pDW-fSf2 |
| fnrS53 | TCCC | pDW-fSf2 |
| fnrS35 | GC | pDW-fSf2 |
| fnrS33 | GC | pDW-fSf2 |
| omrA55 | GC | pDW-oAf2 |
| omrA53 | CG | pDW-oAf2 |
| omrA35 | CG | pDW-oAf2 |
| omrA33 | GG | pDW-oAf2 |
| omrB55 | GC | pDW-oBf2 |
| omrB53 | CG | pDW-oBf2 |
| omrB35 | CG | pDW-oBf2 |
| omrB33 | GG | pDW-oBf2 |
| Spf55 | GC | pDW-sff2 |
| Spf53 | CG | pDW-sff2 |
| Spf35 | CG | pDW-sff2 |
| Spf33 | GG | pDW-sff2 |
| C1 SDM FOR | tagagtagaaa | pDW6-C1 |
| C2 SDM FOR | tagagtagaaag | pDW6-C2 |
| C3 SDM FOR | tagagtagaaagg | pDW6-C3 |
| C1, C2, C3 SDM REV | ttcttagacgatgtaagttcacc | pDW6-C1, pDW6-C2, pDW6-C3 |
| C4 SDM FOR | gtactatttaat | pDW6-C4 |
| C4 SDM REV | tgtacaacagcttcctttctactctattc | pDW6-C4 |
| C5 SDM FOR | ttacgtgagtt | pDW6-C5 |
| C5 SDM REV | tcattaattatgaatat | pDW6-C5 |
| H1 SDM FOR | acatcgtctaagaa | pDW6-H1 |
| H1 SDM REV | aagttcaccatattttttctc | pDW6-H1 |
| S1 SDM FOR | ctatttaatggaatattcaAaattaatgattTgtgagtttccaatggc | pDW6-S1 |
| S1 SDM REV | gccattggaaactcacAaatcattaattTtgaatattccattaaatag | pDW6-S1 |
| S2 SDM FOR | ctatttaatggaatattcaATTttaatgaAATcgtgagtttccaatggc | pDW6-S2 |
| S2 SDM REV | gccattggaaactcacgATTtcattaaAATtgaatattccattaaatag | pDW6-S2 |
| S3 SDM FOR | ctatttaatggaatattcatGGtCaatgaCCacgtgagtttccaatggc | pDW6-S3 |
| S3 SDM REV | gccattggaaactcacgtGGtcattGaCCatgaatattccattaaatag | pDW6-S3 |
| spf-S1 SDM FOR | gaccttttacttcacAaatcggatttggctg | pIB-spf-S1 |
| spf-S1 SDM REV | cagccaaatccgattTgtgaagtaaaaggtc | pIB-spf-S1 |
| spf-S2 SDM FOR | accttttacttcacgATTtcggatttggctgaa | pIB-spf-S2 |
| spf-S2 SDM REV | ttcagccaaatccgaAATcgtgaagtaaaaggt | pIB-spf-S2 |
| sepL-full used with below | aaaaggatccgattgaggccttgttcaag | |
| sepL-ATG | ggggtaccatggtaccggtcgccaccatg | pDW-sepL-ATG |
| sepL+6 | ggggtaccgtaccggtcgccaccatggtg | |
| sepL+9 | ggggtaccccggtcgccaccatggtgagc | |
| sepL+12 | ggggtaccgtcgccaccatggtgagcaag | |
| sepL+15 | ggggtaccgccaccatggtgagcaagggc | |
| sepL+18 | ggggtaccaccatggtgagcaagggcgag | |
| sepL+27 | ggggtaccagcaagggcgaggagctgttc | |
| sepL+30 | ggggtaccaagggcgaggagctgttcacc | |
| sepL+33 | ggggtaccggcgaggagctgttcaccggg | |
| sepL+36 | ggggtaccgaggagctgttcaccggggtg | |
| sepL+39 | ggggtaccagctgttcaccggggtggtg | |
| sepL+42 | ggggtaccgttcaccggggtggtgccc | |
| sepL+45 | ggggtacccaccggggtggtgcccatc | |
| sepL+48 | ggggtaccgggtggtgcccatcctg | |
| sepL+75 | aaaaggtaccttctaattcaaaatctaatg | |
| sepL+78 | aaaaggtaccagattctaattcaaaatcta | |
| sepL+81 | ggggtaccaattaacgcaaaaaaattcttc | |
| sepL+84 | ggggtaccttaacgcaaaaaaattcttctaat | |
| sepL+87 | aaaaggtacctaattgctgagattctaatt | |
| sepL+90 | aaaaggtacccgttaattgctgagattcta | |
| sepL+102 | aaaaggtaccagaatttttttgcgttaattgc | |
| sepL+123 | aaaaggtacctaatggcgaagaaatattagaag | |
| sepL+210 | ggggtaccacctttgcgatatcccaggc |
Figure 2.Predicted and structural analysis of the sepL 5′UTR and early coding sequence. (A) RNAfold prediction of the sepL mRNA region from –82 to +78 to highlight the predicted secondary structure around the RBS and AUG which are shown in green. Predicted CsrA binding sites are shown (27,43) along with Hfq ARN5m2 motifs and Hfq minor and major deletion sites following CRAC analysis (31). The four predicted stem loops are labelled SL1–4. (B) In vivo analysis of the RBS and AUG regions of sepL using SHAPE analysis. Bacteria were treated with either NAI or DMSO, RNA extracted and primer extension performed as described in Materials and Methods. The main regions of interest are indicated on the left-hand side of the figure. The traces on the right-hand side indicate radio-labeling intensity. The gels shown are representative from several analyses carried out over this region. The lack of NAI reactivity either side of stem loop 2 (SL2) supports the predicted structure (Figure 2A) with the RBS embedded within the stem region of SL2.
Figure 3.Mutagenesis of CsrA and Hfq interacting sequences in the sepL 5′ UTR. (A) the predicted secondary structure of sepL 5′ UTR and 5′ CDS on the left-hand side of the panel shows the two AGGnA sequences predicted to interact with CsrA. The Hfq binding peaks, deletions, and ARN5m2 motif are as indicated in Figure 1. A mutation (H1) was introduced into the ARN5m2 motif to disrupt Hfq interactions at this site (peak 703, Figure 1). Four site-specific mutations (C1–4) were introduced to test their impact on CsrA activation of sepL translation while C5 was introduced to restore base pairing in SL4 that may be destabilised by the C4 mutations. (B) Measurement of the wild type and mutated SepL-GFP fusions in either the E. coli O157:H7 strain ZAP193 (high T3 secretor background) or strain Sakai (low T3 secretor). Fluorescence was measured for cultures over a range of optical densities and then adjusted for optical density as described in Materials and Methods. (C) Flow cytometry analysis of SepL-GFP and C1–4 mutations in E. coli O157:H7 ZAP193 (high T3 secretor). Expression of the wild type fusion in the ΔcsrA background indicates minimal levels of secretion in the absence of translational activation. Significance was calculated using a paired t-test for replicate data collected over multiple experiments (panel B, ZAP193 sepL-C4, -C5 and -C4&5). An unpaired t-test was used for all other samples.
Figure 4.Analysis of sRNA mutations on type 3 secretion and specific LEE transcripts. (A) Western blot analysis for EspD (supernatant), EscJ (whole cell) and RecA (whole cell control) from WT and sRNA deletion mutants of E. coli O157:H7 strains Sakai (low T3 secretor) and ZAP193 (high T3 secretor). (B) Bar graphs showing relative expression levels of the SepL+51-GFP fusion (see text for details) in the WT and sRNA deletion backgrounds of E. coli O157:H7 strain Sakai. The asterisk indicates that the mutant did not grow to an OD600 >0.6 under our experimental conditions. (C) Translation of the LEE encoded proteins Ler, SepL and Tir was monitored in WT, Δspf, and ΔmicA backgrounds for both low T3 secretor strain Sakai, and high T3 secretor strain ZAP193. Asterisks indicate P< 0.05.
Figure 5.Analysis of Hfq and Spot42 interactions with the sepL transcript. (A) Two site specific mutations in predicted stem loop (SL) 2 are shown (S1 and S2) along with other features described in Figures 1 and 2. (B) EspA filament staining on the surface of E. coli O157:H7 strain Sakai and the isogenic Δspf and complemented strains. EspA filament staining (green) was carried out as described in Materials and Methods with the bacteria surface stained using anti-O157 (red). (C) Western blot for EspD in bacterial supernatants and RecA from whole cell preparations from WT strain Sakai, the Δspf deletion mutant, and chromosomal knock-ins using spf, the spf-S1, or spf-S2, to replace the deleted region. (D) Predicted base pairing between sepL and Spot42, and compensatory mutations in the sepL 5′ UTR predicted to restore base pairing with the spf-S1 and spf-S2 site-directed mutants. (E) Plasmid-based SepL-GFP fusions carrying the S1 and S2 mutations were assayed in wild type E. coli O157:H7 strain Sakai, the isogenic spf deletion, and chromosomal knock-ins of the spf-S1 and spf-S2 mutations (indicated below). Significance was calculated relative to WT spf and pSepL-GFP fluorescence unless indicated. A single asterisk indicates P≤ 0.1 and a double asterisk indicates P≤ 0.05.
Figure 6.SepL translation and summary model. (A) The predicted RNAfold structure of the 5′ UTR and first 89 nt of sepL CDS is shown for orientation of possible secondary structure absent in sepL truncates shown in panel B. (B) A systematic series of fusions to GFP were constructed into the sepL open reading frame to investigate sequence requirements for expression. All the fusions included the 5′ UTR and natural promoter of sepL (Table 2). The shortest fusion encompassed the native sepL promoter to the initiation codon (ATG). Successive three nucleotide extensions are numbered by how far they extend (in bases) into sepL. The final construct is the full length (FL) fusion used in previous studies (pDW6, Table 2). Expression from this series of constructs was measured in the low secretor strain Sakai. (C) Fluorescence microscopy of selected sepL’-GFP constructs to illustrate transitions in sepL translation. The 81 nt fusion exhibits a clear biphasic expression pattern, with approximately half of the cells expressing GFP. (D) Flow cytometry of sepL truncates presented in panel C. (E) Graph showing the maximum ΔG values for the different truncates fused to eGFP. This provides an indication of when major transitions in structure may occur between the different length fusions. (F) Model of the post-transcriptional regulation leading to transient expression of the sepL transcript. The model is described within the Discussion section of the manuscript. It is proposed that the transcript adopts a structure that initially prevents translation due to poor access to the RBS. CsrA is required for translational activation along with specific sequence in the early part of sepL (1–18 bases). SepL translation is silenced by Hfq-Spot42 binding to occlude the RBS and potentially by direct competition with CsrA. This dynamic is proposed to result in transient SepL translation and assembly of the EspA translocon.